Annapurna Kuppa

716 total citations · 1 hit paper
17 papers, 287 citations indexed

About

Annapurna Kuppa is a scholar working on Epidemiology, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Annapurna Kuppa has authored 17 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Genetics and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Annapurna Kuppa's work include Liver Disease Diagnosis and Treatment (6 papers), Genetic Associations and Epidemiology (4 papers) and Diet, Metabolism, and Disease (4 papers). Annapurna Kuppa is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Genetic Associations and Epidemiology (4 papers) and Diet, Metabolism, and Disease (4 papers). Annapurna Kuppa collaborates with scholars based in United States, India and Canada. Annapurna Kuppa's co-authors include Elizabeth K. Speliotes, Xiaomeng Du, Vincent Chen, Brian Halligan, Wadea Tarhuni, Yanhua Chen, Himi Tripathi, Ahmed Abdel‐Latif, Samuel K. Handelman and Ambarish Kunwar and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Nature Genetics.

In The Last Decade

Annapurna Kuppa

15 papers receiving 285 citations

Hit Papers

Comprehensive genetic study of the insulin resistance mar... 2024 2026 2025 2024 10 20 30 40

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annapurna Kuppa United States 8 117 61 54 45 44 17 287
Yu‐Hong Huang China 9 87 0.7× 55 0.9× 51 0.9× 37 0.8× 25 0.6× 22 366
Francisco Campos‐Pérez Mexico 7 151 1.3× 100 1.6× 64 1.2× 71 1.6× 33 0.8× 9 314
Diego Bailetti Italy 10 92 0.8× 55 0.9× 95 1.8× 25 0.6× 41 0.9× 20 229
Roxana Gutiérrez‐Vidal Mexico 9 175 1.5× 129 2.1× 78 1.4× 89 2.0× 41 0.9× 14 374
Anna Stępień Poland 10 112 1.0× 116 1.9× 59 1.1× 79 1.8× 67 1.5× 24 432
Pierre S. Leclère France 6 169 1.4× 98 1.6× 56 1.0× 81 1.8× 23 0.5× 7 311
Jihoon Shin Japan 11 96 0.8× 100 1.6× 64 1.2× 104 2.3× 26 0.6× 16 348
Konstantinos Stefanakis United States 10 183 1.6× 83 1.4× 116 2.1× 139 3.1× 27 0.6× 20 401
Ellen Riehle United States 6 60 0.5× 93 1.5× 65 1.2× 40 0.9× 49 1.1× 12 315
Monica De Paoli Canada 5 50 0.4× 68 1.1× 78 1.4× 66 1.5× 23 0.5× 9 257

Countries citing papers authored by Annapurna Kuppa

Since Specialization
Citations

This map shows the geographic impact of Annapurna Kuppa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annapurna Kuppa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annapurna Kuppa more than expected).

Fields of papers citing papers by Annapurna Kuppa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annapurna Kuppa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annapurna Kuppa. The network helps show where Annapurna Kuppa may publish in the future.

Co-authorship network of co-authors of Annapurna Kuppa

This figure shows the co-authorship network connecting the top 25 collaborators of Annapurna Kuppa. A scholar is included among the top collaborators of Annapurna Kuppa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annapurna Kuppa. Annapurna Kuppa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chen, Vincent, Annapurna Kuppa, Antonino Oliveri, et al.. (2025). Human genetics of metabolic dysfunction–associated steatotic liver disease: from variants to cause to precision treatment. Journal of Clinical Investigation. 135(7). 11 indexed citations
2.
Oliveri, Antonino, Ryan J. Rebernick, Annapurna Kuppa, et al.. (2024). Comprehensive genetic study of the insulin resistance marker TG:HDL-C in the UK Biobank. Nature Genetics. 56(2). 212–221. 44 indexed citations breakdown →
3.
Cushing, Kelly C., Yanhua Chen, Xiaomeng Du, et al.. (2024). Genetic insight into the relationship between inflammatory bowel disease and Clostridioides difficile infection. mSphere. 9(11). e0056724–e0056724.
4.
Chen, Vincent, Xiaomeng Du, Antonino Oliveri, et al.. (2024). Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohort. Journal of Hepatology. 81(3). 379–388. 20 indexed citations
5.
Kuppa, Annapurna, Yue Chen, Asmita Pant, et al.. (2023). Knockout of murine Lyplal1 confers sex-specific protection against diet-induced obesity. Journal of Molecular Endocrinology. 70(3). 2 indexed citations
6.
Kuppa, Annapurna, et al.. (2023). C-Reactive Protein Levels and Risk of Cardiovascular Diseases: A Two-Sample Bidirectional Mendelian Randomization Study. International Journal of Molecular Sciences. 24(11). 9129–9129. 64 indexed citations
7.
Cushing, Kelly C., Yanhua Chen, Xiaomeng Du, et al.. (2023). Risk Variants in or NearZBTB40ANDNFATC1Increase the Risk of Both IBD and Adverse Bone Health Outcomes Highlighting Common Genetic Underpinnings Across Both Diseases. Inflammatory Bowel Diseases. 29(6). 938–945. 2 indexed citations
8.
Cushing, Kelly C., Xiaomeng Du, Yanhua Chen, et al.. (2022). Inflammatory Bowel Disease Risk Variants Are Associated with an Increased Risk of Skin Cancer. Inflammatory Bowel Diseases. 28(11). 1667–1676. 6 indexed citations
9.
Handelman, Samuel K., Annapurna Kuppa, Yanhua Chen, et al.. (2022). Population‐based meta‐analysis and gene‐set enrichment identifies FXR/RXR pathway as common to fatty liver disease and serum lipids. Hepatology Communications. 6(11). 3120–3131. 10 indexed citations
10.
Pant, Asmita, Yue Chen, Annapurna Kuppa, et al.. (2021). Perturbation of TM6SF2 Expression Alters Lipid Metabolism in a Human Liver Cell Line. International Journal of Molecular Sciences. 22(18). 9758–9758. 6 indexed citations
11.
Sergeev, Yuri V. & Annapurna Kuppa. (2021). Homology modeling and global computational mutagenesis of human myosin VIIa. Journal of Analytical & Pharmaceutical Research. 10(1). 41–48. 2 indexed citations
12.
Chen, Vincent, Xiaomeng Du, Yanhua Chen, et al.. (2021). Genome-wide association study of serum liver enzymes implicates diverse metabolic and liver pathology. Nature Communications. 12(1). 816–816. 75 indexed citations
13.
Chen, Vincent, Xiaomeng Du, Yanhua Chen, et al.. (2021). S1179 PNPLA3 and TM6SF2 Risk Alleles Amplify Effects of Diet on Hepatic Steatosis. The American Journal of Gastroenterology. 116(1). S549–S549.
14.
Kuppa, Annapurna, et al.. (2019). Mysterious Mechanisms of Memory Formation: Are the Answers Hidden in Synapses?. Cureus. 11(9). e5795–e5795. 11 indexed citations
15.
Kuppa, Annapurna, et al.. (2019). Risk of Alcohol Abuse in Humans with Attention-deficit/Hyperactivity Disorder Symptoms. Cureus. 11(10). e5996–e5996. 3 indexed citations
16.
Kuppa, Annapurna, et al.. (2018). A Strange Case of Dissociative Identity Disorder: Are There Any Triggers?. Cureus. 10(7). e2957–e2957. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026